POTENTIAL FOR COST SAVINGS ASSOCIATED WITH A NOVEL IBS BLOOD PANEL FOR DIAGNOSING (IBS-D) ITALIAN PERSPECTIVE PMD 32
INCLUSION OF A NOVEL IBS BLOOD PANEL FOR DIAGNOSING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) A UK PERSPECTIVE PMD 33
A NOVEL IBS DIAGNOSTIC BLOOD PANEL CAN ENHANCE A POSITIVE DIAGNOSTIC STRATEGY VERSUS A STRATEGY OF EXCLUSION FOR PATIENTS WITH (IBS-D) COST IMPLICATIONS FOR DENMARK PMD 34
COST-MINIMIZATION FOR A NOVEL IBS DIAGNOSTIC BLOOD PANEL VERSUS STANDARD EXCLUSIONARY DIAGNOSTIC TESTING FOR IBS-D: A UNITED STATES PERSPECTIVE PMD 35
IMPACT OF A NOVEL IBS DIAGNOSTIC BLOOD PANEL FOR MEXICO COST IMPLICATIONS TO THE MEXICAN PRIVATE PRACTICE FOR (IBS-D) PMD 36
DOWNLOAD ALL POSTERS FOR ITA-UK-DEN-US-MEX
